These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Drug and electrical therapy of supraventricular tachyarrhythmias]. Heisel A; Jung J; Schieffer H Z Kardiol; 2000; 89 Suppl 3():68-74. PubMed ID: 10810788 [TBL] [Abstract][Full Text] [Related]
27. Initial energy for biphasic external electrical cardioversion of atrial fibrillation. Miracapillo G; Costoli A; Addonisio L; Severi S Ital Heart J; 2005 Sep; 6(9):757-60. PubMed ID: 16212079 [TBL] [Abstract][Full Text] [Related]
28. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study. Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005 [TBL] [Abstract][Full Text] [Related]
29. Atrial fibrillation in the new millennium--the role of pacemaker and defibrillator therapy. Mitchell AR Med Sci Monit; 2002 Oct; 8(10):RA233-9. PubMed ID: 12388933 [TBL] [Abstract][Full Text] [Related]
30. Long-term care of the patient with the atrial defibrillator. Mitchell AR; Spurrell PA; Boodhoo LE; Sulke N Am Heart J; 2004 Feb; 147(2):210-7. PubMed ID: 14760315 [TBL] [Abstract][Full Text] [Related]
31. The Food and Drug Administration and atrial defibrillation devices. Chen L; Keane AT; Every NR Am J Manag Care; 1999 Jul; 5(7):899-909. PubMed ID: 10557410 [TBL] [Abstract][Full Text] [Related]
32. Low-energy internal cardioversion in patients with long-lasting atrial fibrillation refractory to external electrical cardioversion: results and long-term follow-up. Gasparini G; Bonso A; Themistoclakis S; Giada F; Raviele A Europace; 2001 Apr; 3(2):90-5. PubMed ID: 11333060 [TBL] [Abstract][Full Text] [Related]
33. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods. Naegeli B; Straumann E; Bertel O Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188 [TBL] [Abstract][Full Text] [Related]
34. Hybrid therapy of atrial fibrillation. Santini M; Pignalberi C; Ricci R; Calò L Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814 [TBL] [Abstract][Full Text] [Related]
36. External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application. Manegold JC; Israel CW; Ehrlich JR; Duray G; Pajitnev D; Wegener FT; Hohnloser SH Eur Heart J; 2007 Jul; 28(14):1731-8. PubMed ID: 17569681 [TBL] [Abstract][Full Text] [Related]
37. Self-limited bursts of atrial fibrillation following successful cardioversion. Nergårdh AK; Rosenqvist M; Frick M Int J Cardiol; 2007 Jun; 119(1):95-100. PubMed ID: 17064786 [TBL] [Abstract][Full Text] [Related]
38. Quality of life after use of the patient activated atrial defibrillator. Spurrell P; Mitchell A; Kamalvand K; Sulke N Int J Clin Pract; 2003; 57(1):30-4. PubMed ID: 12587939 [TBL] [Abstract][Full Text] [Related]